We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04279197
Recruitment Status : Completed
First Posted : February 21, 2020
Last Update Posted : January 3, 2022
Hubei Hospital of Traditional Chinese Medicine
Jingmen No.1 People's Hospital
Wuhan No.1 Hospital
Wuhan Third Hospital
Huangshi Hospital of Traditional Chinese Medicine
Information provided by (Responsible Party):
Liu Chenghai, ShuGuang Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 24, 2021
Actual Study Completion Date : March 24, 2021